A push to vaccinate more people sooner due to a vast increase in supply in Ontario and the emergence of Delta variant has meant fast-changing COVID vaccine eligibility rules.
Pfizer has announced the start of a large study to test the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in children below the age of 12 years.